FIELD: pharmaceutical industry.
SUBSTANCE: invention refers to a pharmaceutical composition possessing antioxidant activity. Pharmaceutical composition, having antioxidant activity, obtained from Galleria mellonella larvae, including thymogen, thymosin-beta, lysozyme, superoxide dismutase, aspartic acid, glutamic acid, glycine, alanine, citric acid, isocitric acid, alpha-ketoglutaric acid in a certain amount.
EFFECT: composition described above is characterized by high content of biologically active components and antioxidant activity.
7 cl, 50 dwg, 23 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF DISEASE CAUSED BY OXIDATIVE STRESS | 2018 |
|
RU2674286C1 |
METHOD OF STRUCTURAL VESSEL ALTERATION CORRECTION IN EXPERIMENT | 2007 |
|
RU2349320C2 |
ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
PEPTIDES SHOWING ANTISTRESS, ANTICONVULSANT AND NEUROPROTECTIVE EFFECT | 1997 |
|
RU2115660C1 |
METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
INFUSION WITH HYPOGLYCEMIC ACTIVITY | 2017 |
|
RU2666398C1 |
AGENT WITH THE ABILITY TO INCREASE LIFESPAN, IMPROVE COGNITIVE PROPERTIES, MOTOR CONTROL AND COORDINATION OF ANIMAL MOVEMENTS | 2022 |
|
RU2801871C1 |
PHARMACEUTICAL COMPOSITION, MEDICATION FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME AND DIABETIC NEPHROPATHY AND METHOD OF OBTAINING THEREOF | 2011 |
|
RU2519744C2 |
PHARMACEUTICAL COMPOSITION SHOWING STRESS-PROTECTIVE ACTION, AND METHOD FOR PREVENTION AND TREATMENT OF FUNCTIONAL OR STRESS-INDUCED DISORDERS | 2009 |
|
RU2455310C2 |
METHOD OF BRAIN MITOCHONDRIA PREPARATION | 0 |
|
SU1745258A1 |
Authors
Dates
2021-01-28—Published
2019-04-24—Filed